These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8644313)

  • 1. The use of immunocytochemistry (LCA and LEU-7) in diagnosis of renal allograft rejection.
    Gibson IW; Marcussen N; Brown RW; Solez K; Truong LD
    Transplant Proc; 1996 Feb; 28(1):457-64. PubMed ID: 8644313
    [No Abstract]   [Full Text] [Related]  

  • 2. Morphometric and immunohistochemical investigation of renal biopsies from patients with transplant ATN, native ATN, or acute graft rejection.
    Marcussen N; Lai R; Olsen TS; Solez K
    Transplant Proc; 1996 Feb; 28(1):470-6. PubMed ID: 8644316
    [No Abstract]   [Full Text] [Related]  

  • 3. CD45 isoforms and lymphocyte activation antigens in acute renal allograft rejection.
    Battochio A; Solez K; Poppema S; Cockfield S; Rayner D
    Transplant Proc; 1996 Feb; 28(1):482-3. PubMed ID: 8644320
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of 214 percutaneous renal allograft biopsies.
    Kim HC; Park SB; Lee SH; Cho WH; Park CH; Park KK
    Transplant Proc; 1994 Aug; 26(4):1997-8. PubMed ID: 8066648
    [No Abstract]   [Full Text] [Related]  

  • 5. Follow-up of patients with borderline changes in renal allograft biopsies: clinical outcome and evaluation of other histological features in addition to tubulitis.
    Papadimitriou J; Drachenberg C; Anderson L; Bartlett S; Johnson L; Klassen D; Hoehn-Saric E; Weir M; Schweitzer E
    Transplant Proc; 1996 Feb; 28(1):517-8. PubMed ID: 8644334
    [No Abstract]   [Full Text] [Related]  

  • 6. Homing of CD4+CD56+ T lymphocytes into kidney allografts during tubular necrosis or rejection.
    Bachetoni A; Lionetti P; Cinti P; Alò P; Molajoni ER; Di Tondo U; Barnaba V; Alfani D; Cortesini R
    Clin Transplant; 1995 Dec; 9(6):433-7. PubMed ID: 8645884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of lesion quantitation for the Banff schema for renal allograft rejection.
    Racusen LC
    Transplant Proc; 1996 Feb; 28(1):489-90. PubMed ID: 8644323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of CD8+ CD45RO+ DR+ T lymphocytes infiltrating the allograft after first-set rejection episodes in kidney transplants.
    Tkaczuk J; Rostaing L; Modesto A; Peres C; Bentouati L; Durand D; Abbal M; Suc JM; Ohayon E
    Transplant Proc; 1994 Feb; 26(1):235-6. PubMed ID: 8108954
    [No Abstract]   [Full Text] [Related]  

  • 9. The Banff classification of renal allograft pathology: where do we go from here?
    Racusen L; Rayner D; Trpkov K; Olsen S; Solez K
    Transplant Proc; 1996 Feb; 28(1):486-8. PubMed ID: 8644322
    [No Abstract]   [Full Text] [Related]  

  • 10. Apoptosis in acute tubular necrosis and acute renal allograft rejection.
    Matsuno T; Nakagawa K; Sasaki H; Ishine N; Inagaki M; Yagi T; Haisa M; Tanaka N; Sakagami K; Orita K
    Transplant Proc; 1994 Aug; 26(4):2170-3. PubMed ID: 8066712
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pathologic diagnosis of renal transplantation].
    Kondo N
    Rinsho Byori; 1990 Feb; 38(2):169-74. PubMed ID: 2329720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks and benefits of graft biopsy in renal transplantation under cyclosporin-A.
    Kiss D; Landmann J; Mihatsch M; Huser B; Brunner FP; Thiel G
    Clin Nephrol; 1992 Sep; 38(3):132-4. PubMed ID: 1395164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine or rejection enhance secretion of von Willebrand factor in renal transplantation.
    Yussim A; Boksenboim G; Ben-Bassat M; Shmueli D; Lustig S; Bar Nathan N; Shaharabani E; Nakache R; Or H; Shapira Z
    Transplant Proc; 1994 Aug; 26(4):2032-3. PubMed ID: 8066661
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of a small series of renal graft biopsies in a Lebanese population.
    Meguerian-Bedoyan Z; Aftimos G
    Transplant Proc; 2001 Aug; 33(5):2678-9. PubMed ID: 11498120
    [No Abstract]   [Full Text] [Related]  

  • 15. Utility of biopsy in kidney transplants with delayed graft function and acute dysfunction.
    Silva DM; Garcia JP; Ribeiro AR; Veronese FJ; Edelweiss MI; Gonçalves LF; Manfro RC
    Transplant Proc; 2007 Mar; 39(2):376-7. PubMed ID: 17362734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of adhesion molecules in allograft renal dysfunction: a distinct diagnostic pattern in rejection and cyclosporine nephrotoxicity.
    Mampaso F; Marcen R; Molina A; Pascual J; Martin A; Bricio T
    Transplant Proc; 1994 Oct; 26(5):2859-60. PubMed ID: 7524222
    [No Abstract]   [Full Text] [Related]  

  • 17. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients.
    Posselt AM; Vincenti F; Bedolli M; Lantz M; Roberts JP; Hirose R
    Transplantation; 2003 Jul; 76(1):190-5. PubMed ID: 12865808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of fine-needle aspiration biopsy in the diagnosis of acute renal transplant dysfunction.
    Gonçalves LF; Manfro R; Rauber L; Edelweiss M; Prompt C
    Transplant Proc; 1992 Dec; 24(6):3083-4. PubMed ID: 1466065
    [No Abstract]   [Full Text] [Related]  

  • 19. Inducible IL-2 on CD8 lymphocytes as a postoperative predictor of rejection in renal allograft recipients.
    Langley J; Dickerman R; Vergne-Marini P; Williams J; Jensik S; Kenyon N; Anderson J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):939-43. PubMed ID: 8442275
    [No Abstract]   [Full Text] [Related]  

  • 20. CD4 monoclonal antibodies in the preclinical dog renal allograft model.
    Watson CJ; Davies HS; Metcalfe SM; Cobbold SP; Rebello PR; Collier DS; Waldmann H; Calne RY
    Transplant Proc; 1993 Feb; 25(1 Pt 1):804-6. PubMed ID: 8438491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.